In this circumstance, the ALDH2 activator Alda-1 still potentiated the insulin secretion of MIN6 cells in both low and high glucose concentrations, suggesting a potential for the treatment of type 2 diabetes subjects. The gene discussed is ALDH2; the disease is type 2 diabetes mellitus.